This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The episclera is the thin layer of vascular tissue overlying the sclera. Inflammation of this layer is referred to as episcleritis. It may be accompanied by scleritis.

It is a relatively common condition which is unilateral in two-thirds of cases. Both sexes are equally affected. It is benign and self-limited. Thirty percent are associated with general medical conditions such as collagen disease, herpes zoster, gout and syphilis. It is a good indicator of disease activity in inflammatory bowel disease, where it is one of the most common ocular manifestations (1).

There are two types - simple and nodular. Simple episcleritis is characterized by a very acute onset. It is mild, sectoral, recurrent and resolves rapidly. The nodular form presents as a localised, raised mobile area of inflammation near the limbus. The nodules may be single or multiple and usually recur.

Symptoms may include mild irritation and photophobia as well as red eye (2).

About 15% of patients develop a mild iritis. Episcleritis is distinguished from conjunctivitis by the localised response and the lack of palpebral conjunctival involvement. A drop of phenylephrine 2.5% causes visible blanching of the episcleral vessels in episcleritis, but will not do so in scleritis. Examination with a slit lamp microscope is also helpful in diagnosis (3).


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.